Previous Article | Next Article 
Journal of Clinical Microbiology, May 2001, p. 1827-1832, Vol. 39, No. 5
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.5.1827-1832.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Persistence of Two Invasive Streptococcus
pneumoniae Clones of Serotypes 1 and 5 in Comparison to That of
Multiple Clones of Serotypes 6B and 23F among Children in
Southern Israel
Nurith
Porat,*
Ronit
Trefler, and
Ron
Dagan
Pediatric Infectious Disease Unit, Soroka
University Medical Center and Faculty of Health Sciences,
Ben-Gurion University of the Negev, Beer Sheva, Israel
Received 3 November 2000/Returned for modification 4 January
2001/Accepted 5 March 2001
 |
ABSTRACT |
We conducted a study to examine the clonal distribution of invasive
serotype 1 and 5 isolates as representatives of serotypes that are
rarely carried by healthy individuals compared to that of invasive
serotype 6B and 23F isolates as representatives of serotypes often
carried by young children for prolonged periods. All invasive serotype
1, 5, 6B, and 23F isolates recovered from blood cultures during January
1995 to May 1999 were analyzed; these included 66 serotype 1, 30 serotype 5, 11 serotype 6B, and 15 serotype 23F isolates. One hundred
thirty-three nasopharyngeal (NP) isolates of the indicated four
serotypes from healthy children were also studied. The strains were
characterized using serotyping, antimicrobial susceptibility testing,
and pulsed-field gel electrophoresis profiling. We found that both
invasive and NP serotype 1 and 5 isolates were susceptible to
penicillin and that each serotype showed only one clonal type. In
contrast, serotype 6B and 23F strains showed different phenotypic
characteristics as well as multiple clonal types; 10 clones were
identified among 6B isolates, and 11 clones were identified among 23F isolates.
 |
INTRODUCTION |
Infections due to
Streptococcus pneumoniae continue to cause significant
morbidity and mortality in children (14). More than 90 pneumococcal types have been identified on the basis of differences in
their structures and the antigenicities of their capsular
polysaccharides (8). The levels of virulence of S. pneumoniae strains differ between serogroups and types, with
serogroups 1, 2, 3, 5, 7, 14, 16, 25, 28, 36, 43, 46, and 47 being more
virulent and more likely to cause invasive disease than serogroups 6, 18, 19, and 23, which are recovered frequently from healthy carriers (15, 17).
The frequencies of disease-causing types have been shown to differ
according to geographic region (12). The serotype
distribution for children in developing countries tends to be somewhat
different than in developed countries. Serotypes 1 and 5 are important
types in developing countries and less so in developed settings. These two serotypes are the dominant cause of disease in southern Israel (N. Porat, R. Trefler, and R. Dagan, Abstr. Second Int. Symp. Pneumococci
Pneumococcal Dis., abstr. P-12, 2000), South America (15, 18,
20), Africa (3), and India (11).
However, other serotypes (6B, 14, 19F, and 23F) are common causes of
invasive diseases in all settings and these types are also most
frequently associated with drug resistance.
In the last decade the two most common capsular types among pediatric
invasive isolates in southern Israel were 1 (23%) and 5 (10%); these
two serotypes were rare among asymptomatic carriers. Other serotypes,
like 6B and 23F, highly prevalent in the nasopharyngeal (NP) flora of
healthy children, were less frequently associated with invasive
disease: 4 and 3% of 6B and 23F isolates, respectively, were
associated with invasive disease during 1989 to 1999 (6; Porat et al., Abstr. Second Int. Symp. Pneumococci Pneumococcal Dis., 2000).
New subtyping methods using DNA fingerprint profiles provide additional
discriminatory power compared with that of serotyping alone. These
methods are extremely important in cases where phenotypic characteristics are insufficient to show the relatedness among strains,
e.g., strains carrying the same capsular type and antimicrobial resistance pattern. In this study we applied one of the genotyping methods, namely, pulsed-field gel electrophoresis (PFGE), to look at
the clonal distribution of strains carrying capsular types 1, 5, 6B,
and 23F. Our goal was to see the clonal diversity of serotypes that are
frequently found among invasive isolates and to compare it with that of
serotypes that are less common among invasive strains but often carried
by young children for prolonged periods. The basic hypothesis was that
invasive serotypes that are not carried in the nasopharynx for
prolonged periods will be represented by a more homogenous population
due to their lower chance of interacting with other organisms and/or
being exposed to antibiotic pressure, resulting in genetic transformation.
 |
MATERIALS AND METHODS |
Bacterial isolates.
The 255 isolates included in this study
were recovered from children living in southern Israel, aged 0 to 12 years. The study population in this area consisted of Jewish children
with a lifestyle resembling that of developed populations and Moslem
Bedouin children with much lower standards of living, representing that
of developing populations. All isolates of serotypes 1, 5, 6B, and 23F
recovered from blood cultures of children aged 0 to 12 years during
January 1995 through May 1999 at the Soroka University Medical Center were analyzed. These included 66 serotype 1, 30 serotype 5, 11 serotype
6B, and 15 serotype 23F isolates (total of 122 isolates). In cases of
strains with identical PFGE patterns originating from an outbreak
(5) or where several cultures were taken from the same
child during the course of the disease episode, resulting in
genetically identical strains, only one isolate per child was included
in the study. The 133 NP isolates included all serotype 1 and 5 strains
isolated during the above-indicated time period and organisms of
serotypes 6B and 23F which were chosen randomly from a collection of
4,600 strains recovered from pediatric healthy carriers in southern
Israel. Only 13 serotype 1 and 15 serotype 5 epidemiologically
unrelated isolates from healthy carriers were found. The 53 6B isolates
and 52 23F isolates were randomly chosen from a total of 205 6B and 444 23F isolates (Table 1). In cases where an
epidemiological linkage was detected among strains with identical PFGE
patterns, only one representative isolate was included in the study.
This exclusion criterion refers to (i) strains originating from the
same day care center during a period of 6 months or less and (ii)
repeated cultures obtained from the same child during a 6-month period
or less.
View this table:
[in this window]
[in a new window]
|
TABLE 1.
Survey of S. pneumoniae organisms isolated
from children in southern Israel during January 1995 to May 1999
|
|
Isolates were confirmed as S. pneumoniae by inhibition with
optochin and by a positive slide agglutination test (Phadebact; Pharmacia Diagnostics, Uppsala, Sweden). One S. pneumoniae colony per culture was subcultured, harvested,
and kept frozen at
70°C for further testing.
Antibiotic susceptibility testing.
Testing of isolate
susceptibility to penicillin, erythromycin, tetracycline,
chloramphenicol, and trimethoprim-sulfamethoxazole (SXT) was performed
by the disk diffusion method of Bauer and Kirby according to NCCLS
recommendations (13). Isolates exhibiting an inhibition
zone with a radius of
19 mm around a 1-µg-oxacillin disk were
further tested for susceptibility to penicillin by means of the E-Test
(AB Biodisk, Solna, Sweden) according to the manufacturer's instructions (10). Antibiotic susceptibility testing was
carried out on all the isolates described in Table 1.
Serogrouping and serotyping.
Serogrouping and serotyping of
S. pneumoniae was done by means of the quellung reaction
using antisera provided by the Statens Serum Institute of Copenhagen,
Denmark (1).
PFGE.
Chromosomal DNA fragments, generated by
SmaI digestion, were prepared and analyzed as described
elsewhere (16). A contour-clamped homogeneous electric
field DRIII apparatus (Bio-Rad Laboratories, Richmond, Calif.) was used
for running the gels. Running conditions were 23 h at 11.3°C at
200 V ramped with an initial forward time of 5 s and a final
forward time of 35 s. Gels were stained with ethidium bromide and
photographed. Interpretation of strain relatedness on the basis of PFGE
pattern was according to current consensus (19).
 |
RESULTS |
Distribution of types.
Table 1 shows the yearly distribution
of the strains and their partitioning among Jewish and Bedouin
children. A total of 255 S. pneumoniae strains were
analyzed, 133 of which were from healthy carriers and 122 of which were
from children with invasive disease. The 122 invasive strains included
all serotype 1, 5, 6B, and 23F organisms that were cultured at the
Soroka University Medical Center in southern Israel during January 1995 to May 1999. The 133 NP isolates included all 13 (0.28%) serotype 1 isolates, all 15 (0.33%) serotype 5 isolates, and 53 6B isolates and
52 23F isolates that were randomly chosen from our collection.
As can be seen in Table 1, the distribution of invasive S. pneumoniae strains carrying serotypes 1 and 5 differed
significantly between Jews and Bedouins (P = 0.002);
81.8% of the invasive type 1 isolates and 66.7% of the invasive type
5 isolates were found in the Bedouin population, whereas no significant
difference was found for the invasive isolates of serotypes 6B and 23F.
Antimicrobial susceptibility.
Table
2 summarizes the susceptibility testing
results for the six antimicrobial agents evaluated in this study. All
the strains carrying capsular serotype 1 or 5 were susceptible to
penicillin, erythromycin, clindamycin, tetracycline, and
chloramphenicol; 52% of serotype 1 isolates and 36% of serotype 5 isolates were not susceptible to SXT. Isolates carrying serotypes 6B
and 23F presented a completely different resistance pattern. Of 64 isolates with serotype 6B, 33 (52%) were not susceptible to penicillin and 36 (56%) were not susceptible to three or more different
antimicrobial agents. Among the 67 serotype 23F isolates, 60 (90%)
were not susceptible to penicillin and 14 (21%) were not susceptible
to three or more different antimicrobial agents. Different resistance rates were also noticed for organisms isolated from the nasopharynx compared to those isolated from blood or cerebrospinal fluid (CSF).
Molecular typing.
Analysis by PFGE provided data on the
variability of the genetic background for each serotype. All type 1 isolates, both invasive and NP, belonged to the same clonal type (Fig.
1); three PFGE patterns differing from
each other by no more than five bands represented 86% of all type 1 isolates and 92% of the invasive isolates. Type 5 isolates also shared
one clonal type (Fig. 2), with 62% of
the isolates showing indistinguishable PFGE patterns and the rest
distributed into eight closely related profiles. The PFGE pattern of
serotype 5 isolates studied here resembles that of the serotype 5 "Colombian clone" (18).

View larger version (70K):
[in this window]
[in a new window]
|
FIG. 1.
PFGE patterns generated by SmaI digestion of
S. pneumoniae serotype 1 isolates recovered from children in
Southern Israel during 1994 to 1999. Lanes 1 and 30 contain a lambda
ladder; lanes 2 and 29 contain a reference strain, R6, used as a
molecular weight marker. Numbers on the left show molecular sizes in
kilobases. Lanes 3, 14, 15, and 19 to 21 contain NP isolates; lanes 4 to 13, 16, 17, and 22 to 28 contain blood isolates; lane 18 contains a
CSF isolate.
|
|

View larger version (62K):
[in this window]
[in a new window]
|
FIG. 2.
PFGE patterns generated by SmaI digestion of
S. pneumoniae serotype 5 isolates recovered from children in
Southern Israel during 1994 to 1999. Lanes 1 and 30 contain a lambda
ladder; lanes 2 and 29 contain a reference strain, R6, used as a
molecular weight marker. Numbers on the left show molecular sizes in
kilobases. Lanes 3, 7, 11, 12, 18, 19, and 24 contain NP isolates;
lanes 4 to 6, 8 to 10, 13 to 17, 20 to 23, and 25 to 27 contain blood
isolates; lane 28 contains a CSF isolate.
|
|
In contrast to serotypes 1 and 5, pneumococci of capsular type 6B (Fig.
3) and 23F (Fig.
4) showed a large diversity in their phenotypic and genotypic characteristics: six clonal types (arbitrarily named 6B-1 to 6B-6) were identified among the 11 invasive serotype 6B
isolates; all of them plus four additional PFGE patterns (6B-7 to
6B-10) were present among the 53 serotype 6B NP isolates (Fig. 5). Clone 6B-4 resembled the "Icelandic
6B clone" (16). Multiple clonal types were also found
among the 23F isolates (Fig. 4); three clonal types were found among
the 15 invasive isolates (23F-1 to 23F-3), and eight types (23F-1 to
23F-8) were found among the 52 NP isolates (Fig. 5). For all capsular
types examined here, the clones found among invasive isolates were also
detected among the organisms recovered from the NP samples.

View larger version (67K):
[in this window]
[in a new window]
|
FIG. 3.
PFGE patterns generated by SmaI digestion of
S. pneumoniae serotype 6B isolates recovered from children
in Southern Israel during 1994 to 1999. Lanes 1 and 30 contain a lambda
ladder; lane 2 contains a reference strain, R6, used as a molecular
weight marker. Numbers on the left show molecular sizes in kilobases.
Lanes 5 to 9, 12 to 13, 15 to 23, 25, and 27 to 29 contain NP isolates;
lanes 3, 4, 10, 11, 14, 24, and 26 contain blood isolates.
|
|

View larger version (69K):
[in this window]
[in a new window]
|
FIG. 4.
PFGE patterns generated by SmaI digestion of
S. pneumoniae serotype 23F isolates recovered from children
in Southern Israel during 1994 to 1999. Lanes 1 and 30 contain a lambda
ladder; lanes 2 and 29 contain a reference strain, R6, used as a
molecular weight marker. Numbers on the left show molecular sizes in
kilobases. Lanes 5, 7, 10 to 16, 18 to 21, and 23 to 28 contain NP
isolates; lanes 3, 4, 6, 8, 17, and 22 contain blood isolates; lane 9 contains a CSF isolate.
|
|

View larger version (94K):
[in this window]
[in a new window]
|
FIG. 5.
Clonal distribution of NP and invasive (blood or CSF)
S. pneumoniae isolates carrying serotypes 1, 5, 6B, and 23F
recovered from children in Southern Israel during 1994 to 1999. The
numbers in the keys attached to the figures of serotypes 6B and 23F
refer to the clonal types shown in Fig. 3 and 4. The numbers in the bar
graphs are percentages.
|
|
 |
DISCUSSION |
There is no doubt that NP carriage plays a crucial role in
S. pneumoniae epidemiology and disease (4;
P. Yagupsky, N. Peled, and R. Dagan, Abstr. 36th Intersci.
Conf. Antimicrob. Agents Chemother., abstr. C-48, 1996). From this site
the pneumococcus may spread to adjacent mucosal surfaces to cause
mucosal infections, such as otitis and pneumonia, or invade the
bloodstream and cause systemic infections, such as bacteremia and
meningitis. However, the frequency with which certain serotypes cause
an invasive disease is not necessarily reflected in their prevalence as
serotypes carried in the nasopharynx.
The two most common capsular types among pediatric invasive isolates in
southern Israel in the last 10 years were 1 (23%) and 5 (10%) and
were most frequently associated with low-socioeconomic-level, overcrowded populations like that of the Bedouins and with outbreaks (5). These serotypes were infrequently detected among
healthy carriers. In contrast, serotypes 6B and 23F were the most
common serotypes found in the nasopharynx as part of the normal flora but were rare in invasive diseases.
These two groups of serotypes differed markedly in their resistance
patterns. Organisms of the two invasive serotypes with capsular types 1 and 5 presented similar resistance patterns and were susceptible to all
antimicrobial agents tested (penicillin, erythromycin, tetracycline,
and chloramphenicol) except SXT. However, most of the strains belonging
to serotypes 6B and 23F were not susceptible to penicillin, showing
considerable heterogeneity in their resistance pattern to other
antimicrobial agents as well. While none of the invasive serotypes were
resistant to more than one antimicrobial agent, high percentages of the
strains belonging to the carried serotypes were multidrug resistant:
56% of serotype 6B and 21% of serotype 23F.
The homogeneity of the invasive strains belonging to serotypes 1 and 5 compared with the diversity of 6B and 23F was further examined by
looking at the genetic background of the strains. Organisms of the two
invasive serotypes, 1 and 5, appeared to be genetically related, with
each one of them having a single clonal origin despite their being
collected during a long period of time (5.5 years). In contrast,
pneumococci of capsular types 6B and 23F were represented by multiple
clonal types: 10 for type 6B and 8 for 23F. For all capsular types
examined here, the same clones were detected both in the nasopharynx
and in blood or CSF.
Previous reports have documented genetic diversity to be higher among
penicillin-susceptible than among non-penicillin-susceptible S. pneumoniae strains (7, 20, 21). Increasing penicillin MICs for organisms was associated with decreasing genetic variability, fewer serotypes, and a higher probability of multidrug resistance. While the exact mechanism of this relationship is not clear, one could
hypothesize that resistance to antimicrobial agents provides an
advantage which supports the survival of the organism in the normal
flora. This postulate was further validated by the extensive international spread of a relatively few multidrug-resistant clones such as the serotype 23F "Spanish/USA" clone and the serotype 14/9V
"French/Spanish" clone (9).
In this study we describe two penicillin-susceptible invasive clones
which tend to persist in our region for a long period of time without
undergoing a major genetic transformation. These serotypes are rarely
found in the nasopharynxes of children and thus have fewer chances of
exchanging genetic material with the environment and fewer chances of
being exposed to antibiotic pressure. We speculate that the poor
adaptation of these serotypes to mucosal surfaces is one of the factors
controlling their low tendency to acquire genes from other NP bacterial
inhabitants, resulting in DNA homogeneity. The other less pathogenic
serotypes might be more prone to long-term colonization and thus more
inclined to multiple antibiotic exposure. Preliminary laboratory
investigations of pneumococcal infection in a mouse model carried out
by Azoulay-Dupuis et al. (2) have suggested a complex
relationship among capsular type, penicillin susceptibility, and
virulence. Based on our data, the capsular type seems to be the
dominant factor in the virulence of S. pneumoniae and in its
tendency to acquire resistance genes. Further studies of the
polysaccharide compositions of the invasive versus noninvasive
serotypes may shed some light on the adhesion mechanism of S. pneumoniae to epithelial cells and its role in colonization.
Moreover, characteristics associated with the clonality of serotypes 1 and 5 may represent an advantage for invasiveness, from a knowledge of
which one can study the genetic mechanism involved in S. pneumoniae pathogenicity.
 |
ACKNOWLEDGMENT |
This study was partially supported by grant 4520 from the
Ministry of Health, Jerusalem, Israel.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Pediatric
Infectious Disease Unit, Ben Gurion University of the Negev, Soroka
Medical Center, Beer Sheva, Israel 84101. Phone: 972-8-6400839. Fax:
972-8-6232334. E-mail: npurat{at}bgumail.bgu.ac.il.
 |
REFERENCES |
| 1.
|
Austrian, R.
1976.
The quellung reaction, a neglected microbiologic technique.
Mt. Sinai J. Med.
43:699-709[Medline].
|
| 2.
|
Azoulay-Dupuis, E.,
V. Rieux,
M. Muffat-Joly,
J. P. Bedos,
E. Vallee,
C. Rivier,
R. Isturiz,
C. Carbon, and P. Moine.
2000.
Relationship between capsular type, penicillin susceptibility and virulence of human Streptococcus pneumoniae isolates in mice.
Antimicrob. Agents Chemother.
44:1575-1577[Abstract/Free Full Text].
|
| 3.
|
Bogaerts, J.,
P. Lepage,
H. Taelman,
D. Rouvroy,
J. Batungwanayo,
P. Kestelyn,
D. G. Hitimana,
P. Van de Perre,
J. Vandepitte,
L. Verbist, and J. Verhaegen.
1993.
Antimicrobial susceptibility and serotype distribution of Streptococcus pneumoniae from Rwanda, 1984-1990.
J. Infect.
27:157-168[CrossRef][Medline].
|
| 4.
|
Dagan, R.,
R. Melamed,
M. Muallem,
L. Piglansky,
D. Greenberg,
O. Abramson,
P. M. Mendelman,
N. Bohidar, and P. Yagupsky.
1996.
Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine.
J. Infect. Dis.
174:1271-1278[Medline].
|
| 5.
|
Dagan, R.,
S. Gradstein,
I. Belmaker,
N. Porat,
Y. Siton,
G. Weber,
J. Janco, and P. Yagupsky.
2000.
An outbreak of Streptococcus pneumoniae serotype 1 in a closed community in southern Israel.
Clin. Infect. Dis.
30:319-321[CrossRef][Medline].
|
| 6.
| Fraser, D., N. Givon-Lavi, N. Bilenko, and R. Dagan. A decade (1989-1998) of pediatric invasive pneumococcal
disease in two populations residing in one geographic location:
implications for vaccine choice. Clin. Infect. Dis, in press.
|
| 7.
|
Hall, L. M. C.,
R. A. Whiley,
B. Duke,
R. C. George, and A. Efstratiou.
1996.
Genetic relatedness within and between serotypes of Streptococcus pneumoniae from the United Kingdom: analysis of multilocus enzyme electrophoresis, pulsed-field gel electrophoresis, and antimicrobial resistance patterns.
J. Clin. Microbiol.
34:853-859[Abstract].
|
| 8.
|
Henrichsen, J.
1995.
Six newly recognized types of Streptococcus pneumoniae.
J. Clin. Microbiol.
33:2759-2762[Abstract].
|
| 9.
|
Hermans, P. W. M.,
K. Overweg,
M. Sluijter, and R. Groot.
2000.
Penicillin-resistant Streptococcus pneumoniae: an international molecular epidemiological study, p. 457-466.
In
A. Tomasz (ed.), Streptococcus pneumoniae: molecular biology & mechanisms of disease. Marry Ann Liebert, Inc., Publishers, Larchmont, N.Y.
|
| 10.
|
Jacobs, M. R.,
S. Bajaksouzian,
P. C. Appelbaum, and A. Bolstrom.
1992.
Evaluation of the E-Test for susceptibility testing of pneumococci.
Diagn. Microbiol. Infect. Dis.
15:473-478[CrossRef][Medline].
|
| 11.
|
John, T. J.,
R. Pai,
M. K. Lalitha,
M. V. Jesudason,
K. N. Brahmadathan,
G. Sridharan, and M. C. Steinhoff.
1996.
Prevalence of pneumococcal serotypes in invasive diseases in southern India.
Indian J. Med. Res.
104:205-207[Medline].
|
| 12.
|
Musher, D. M.,
R. F. Brieman, and A. Tomasz.
2000.
Streptococcus pneumoniae: at the threshold of the 21st century, p. 485-466.
In
A. Tomasz (ed.), Streptococcus pneumoniae: molecular biology & mechanisms of disease. Mary Ann Liebert, Inc., Publishers, Larchmont, N.Y.
|
| 13.
|
National Committee for Clinical Laboratory Standards.
1999.
Performance standards for antimicrobial susceptibility testing: 9th informational supplement, vol. 19.
, no. 1. M100-S9. National Committee for Clinical Laboratory Standards, Wayne, Pa.
|
| 14.
|
Robbins, J. B.,
R. Austrian,
C. J. Lee,
S. C. Rastogi,
G. Schiffman,
J. Henrichsen,
P. H. Makela,
C. V. Broome,
R. R. Facklam,
R. H. Tiesjema, and J. C. Parker, Jr.
1983.
Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups.
J. Infect. Dis.
148:1136-1159[Medline].
|
| 15.
|
Scott, J. A. G.,
A. J. Hall,
R. Dagan,
J. M. S. Dixon,
S. J. Eykyn,
A. Fenoll,
M. Hortal,
L. P. Jette,
J. H. Jorgensen,
F. Lamothe,
C. Latorre,
J. T. Macfarlane,
D. M. Shlaes,
L. E. Smart, and A. Taunay.
1996.
Serotype-specific epidemiology of Streptococcus pneumoniae: association with age, sex and geography in 7,000 episodes of invasive disease.
Clin. Infect. Dis.
22:973-981[Medline].
|
| 16.
|
Soares, S.,
K. G. Kristinsson,
J. M. Musser, and A. Tomasz.
1993.
Evidence for the introduction of a multiresistant clone of serotype 6B Streptococcus pneumoniae from Spain to Iceland in the late 1980s.
J. Infect. Dis.
168:158-163[Medline].
|
| 17.
|
Takala, A. K.,
J. Vuopio-Varkila,
E. Tarkka,
M. Leinonen, and J. M. Musser.
1996.
Subtyping of common pediatric pneumococcal serotypes from invasive disease and pharyngeal carriage in Finland.
J. Infect. Dis.
173:128-135[Medline].
|
| 18.
|
Tamayo, M.,
R. Sa-Leao,
I. S. Sanches,
E. Castaneda, and H. de Lencastre.
1999.
Dissemination of a chloramphenicol- and tetracycline-resistant but penicillin-susceptible invasive clone of serotype 5 Streptococcus pneumoniae in Colombia.
J. Clin. Microbiol.
37:2337-2342[Abstract/Free Full Text].
|
| 19.
|
Tenover, F. C.,
R. D. Arbeit,
R. V. Goering,
P. A. Mickelsen,
B. E. Murray,
D. H. Persing, and B. Swaminathan.
1995.
Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.
J. Clin. Microbiol.
33:2233-2239[Medline].
|
| 20.
|
Tomasz, A.,
A. Corso, and Members of the PAHO/Rockefeller University Workshop (E. P. Severina, G., Echaniz-Aviles, M. C. de Cunto Brandileone, T. Camou, E. Castaneda, O. Figueroa A. Rossi, and J. L. di Fabio).
1998.
Molecular epidemiologic characterization of penicillin-resistant Streptococcus pneumoniae invasive pediatric isolates recovered in six Latin-American countries: an overview.
Microb. Drug Resist.
4:195-207[Medline].
|
| 21.
|
Vaz Pato, M. V.,
C. B. de Carvalho,
A. Tomasz, and the Multicenter Study Group.
1995.
Antibiotic susceptibility of Streptococcus pneumoniae isolates in Portugal. A multicenter study between 1989 and 1993.
Microb. Drug Resist.
1:59-69[Medline].
|
Journal of Clinical Microbiology, May 2001, p. 1827-1832, Vol. 39, No. 5
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.5.1827-1832.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Chiou, A.-C., Andrade, S. S., Almeida, S. C. G., Zanella, R. C., Andrade, A.-L., Brandileone, M.-C. d. C.
(2008). Molecular assessment of invasive Streptococcus pneumoniae serotype 1 in Brazil: evidence of clonal replacement. J Med Microbiol
57: 839-844
[Abstract]
[Full Text]
-
Harrington, S. M., Stock, F., Kominski, A. L., Campbell, J. D., Hormazabal, J. C., Livio, S., Rao, L., Kotloff, K. L., Sow, S. O., Murray, P. R.
(2007). Genotypic Analysis of Invasive Streptococcus pneumoniae from Mali, Africa, by Semiautomated Repetitive-Element PCR and Pulsed-Field Gel Electrophoresis. J. Clin. Microbiol.
45: 707-714
[Abstract]
[Full Text]
-
Gonzalez, B. E., Hulten, K. G., Kaplan, S. L., Mason, E. O. Jr.
(2004). Clonality of Streptococcus pneumoniae Serotype 1 Isolates from Pediatric Patients in the United States. J. Clin. Microbiol.
42: 2810-2812
[Abstract]
[Full Text]
-
Greenberg, D., Dagan, R., Muallem, M., Porat, N.
(2003). Antibiotic-Resistant Invasive Pediatric Streptococcus pneumoniae Clones in Israel. J. Clin. Microbiol.
41: 5541-5545
[Abstract]
[Full Text]
-
Brueggemann, A. B., Spratt, B. G.
(2003). Geographic Distribution and Clonal Diversity of Streptococcus pneumoniae Serotype 1 Isolates. J. Clin. Microbiol.
41: 4966-4970
[Abstract]
[Full Text]
-
Gamboa, L., Camou, T., Hortal, M., Castaneda, E.
(2002). Dissemination of Streptococcus pneumoniae Clone Colombia5-19 in Latin America. J. Clin. Microbiol.
40: 3942-3950
[Abstract]
[Full Text]